Related trials
OPTIMA, 2009 - immediate invasive management vs delayed invasive strategy
TIMACS, 2009 - early invasive management vs delayed invasive strategy
ABOARD, 2009 - immediate invasive management vs delayed invasive strategy
ICTUS, 2007 - routine invasive strategy vs concervative strategy
NQWMI (Eisenberg), 2005 - routine invasive strategy vs concervative strategy
ISAR-COOL, 2003 - early intervention vs early strategy
RITA 3, 2002 - routine invasive strategy vs concervative strategy
VINO, 2002 - routine invasive strategy vs concervative strategy
TACTICS-TIMI 18 elderly (sub group), 2001 - routine invasive strategy vs concervative strategy
TACTICS-TIMI 18, 2001 - routine invasive strategy vs concervative strategy
TRUCS, 2000 - routine invasive strategy vs concervative strategy
FRISC 2, 1999 - routine invasive strategy vs concervative strategy
MATE, 1998 - routine invasive strategy - noncomptemporary vs concervative strategy
VANQWISH, 1998 - routine invasive strategy - noncomptemporary vs concervative strategy
TIMI 3B, 1995 - t-PA vs placebo
TIMI 3B (PTCA), 1994 - routine invasive strategy - noncomptemporary vs concervative strategy
TAUSA, 1994 - intracoronary urokinase vs placebo
TIMI 3A, 1993 - t-PA vs placebo
Freeman, 1992 - t-PA vs placebo
UNASEM, 1992 - anistreplase vs placebo
charbonnier, 1992 - t-PA vs placebo
van der Brand, 1991 - t-PA vs placebo
Ardissino, 1990 - t-PA vs placebo
Williams, 1990 - t-PA vs placebo
Nicklas, 1989 - t-PA vs placebo
See also:
All acute coronary syndrome clinical trials
All clinical trials of myocardial revascularization
All clinical trials of routine invasive strategy
|
|
the Italian Elderly ACS study study, 0
|
|
[NCT00510185]
Ongoing trial
|
Treatments
| Studied treatment |
early aggressive approach
|
| Control treatment |
initially conservative approach
|
Patients
| Patients |
patients older than 74 years of age with NSTEACS |
| Inclusion criteria |
within 48 h of the most recent ischemic symptoms; transient ischemic ECG changes and/or CKMB/Tn elevation |
| Exclusion criteria |
secondary ischemia, ongoing ischemia, or heart failure, despite optimal therapy or recent coronary intervention, serum creatinine more than 2.5 mg/dl, high bleeding risk, and severe concomitant disease |
Method and design
| Randomized effectives |
NA / NA (studied vs. control) |
| Primary endpoint |
deat, MI, stroke, rehospitalization |
Results
No results available for this trial
- ongoing study
Reference(s)
-
Savonitto S, De Servi S, Petronio AS, Bolognese L, Cavallini C, Greco C, Indolfi C, Visconti LO, Piscione F, Ambrosio G, Galvani M, Marzocchi A, Santilli I, Steffenino G, Maseri A.
Early aggressive vs. initially conservative treatment in elderly patients with non-ST-elevation acute coronary syndrome: the Italian Elderly ACS study..
J Cardiovasc Med (Hagerstown) 2008;9:217-26
Pubmed
|
Hubmed
| Fulltext
|